We found significantly lower protein levels of Foxp3 [% of CD4+] and FoxP3 [% of CD4+ CD25+] in patients with early MASLD and advanced MASLD compared to higher values in the control group (p < 0.05). The gene discussed is FOXP3; the disease is metabolic dysfunction-associated steatotic liver disease.